The North America home insemination products market is expected to grow at a whopping CAGR of 7.61% from 2024 to 2029 and be worth USD 1.98 billion by 2029 from USD 1.37 billion in 2024.
The North America market is estimated to grow due to key driving factors like growing support from government authorities in approving the latest technological developments and rising infertility problems among men and women associated with lifestyle changes.
Infertility is common in developed countries. In the United States, out of 100 couples, about 12 to 13 of the couples have trouble becoming pregnant. About 10 out of 100 (6.1 million) women in the U.S. aged 26–40 years have difficulty becoming pregnant or staying pregnant, based on the Centers for Disease Control and Prevention. Hence, women are opting more for home insemination, which provides privacy and ease. As a result, key medical organizations are keen on investing more in Home Insemination products, and this is expected to drive the North American home insemination market growth during the forecast period (2023-2028).
Stringent government laws and rising concern about safety are set to hamper the expansion of the North American home Insemination market. There is high possibility of a woman giving birth to twins or triplets hampering the expansion of the home Insemination Market over the forecast period. The market is predicted to experience slow growth during the conjecture period due to expensive procedures of reproductive techniques.
Impact of COVID-19 on the North America home insemination market:
The recent outbreak of the Coronavirus has turned the spotlight on the healthcare industry and subsequently affected the Home Insemination market. Severe shortages of critical medical supplies and a rapid increase in the number of COVID-19 cases have resulted in a revolution and thus affected the evolution in the healthcare ecosystems. Following government measures, particularly stay-at-home orders, and social distancing norms, doctors are postponed preventing the spread of Coronavirus. Further, supply chain disruptions and movement restrictions have created a logistical nightmare for market players, resulting in severe product shortages in the global marketplace.
This research report on the North America home insemination products market has been segmented and sub-segmented into the following categories.
North America Home Insemination Products Market - By Procedure:
The intrauterine insemination sub-segment is to lead the dominant shares of the market. Rising investments in the improvement of healthcare are leveling up the demand of the market.
North America Home Insemination Products Market – By Product Type:
Among these, the insemination kits segment is estimated to be the fastest-growing segment in terms of value because of the growing geriatric population and is predicted to generate higher revenue during the foreseen period
North America Home Insemination Products Market – By End-user:
The fertility centers segment is estimated to carry the largest share of the regional market during the forecast period. Focus on the development of new innovative kits in favor of the end-user is likely to flourish the growth rate of this segment.
North America Home Insemination Products Market – By Region:
The demand for home insemination kits in the United States is gearing up for the past few years owing to increasing disposable income. North America dominated the home Insemination Market in 2020 with a share of over 41.02%. This is because of the growing demand for Home Insemination by single mothers & lesbian couples and the increasing prevalence of infertility among adults. Technological advancements, favorable rules and regulations, and increasing health sector and private sector investments are factors expanding the growth rate of the home Insemination Market in North America.
KEY MARKET PLAYERS:
The major key players in the North America Home Insemination Products Market are Rocket Medical plc, INVO Bioscience, Medgyn Products, Inc, Kitazato Corporation, Fujifilm Irvine Scientific, Genea Limited, Rinovum Women's Health, LLC, Vitrolife, Hi-Tech Solutions.
RECENT HAPPENINGS IN THE MARKET:
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]